<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-132870" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Anesthetic Considerations in Electroconvulsive Therapy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Reasoner</surname>
            <given-names>Jeremiah</given-names>
          </name>
          <aff>Baylor, Scott and White Medical Center- Temple</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rondeau</surname>
            <given-names>Bryan</given-names>
          </name>
          <aff>Baylor Scott &#x00026; White</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jeremiah Reasoner declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bryan Rondeau declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-132870.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Electroconvulsive therapy is a treatment for severe major depressive disorder and other psychiatric conditions. It involves inducing a seizure in a patient with one of these conditions and effectively reduces symptoms. General anesthesia is used to provide safe conditions for the procedure. This activity overviews the anesthetic considerations for inducing and maintaining anesthesia by the interprofessional team for electric convulsive therapy patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pharmacology of methohexital in the setting of electroconvulsive therapy.</p></list-item><list-item><p>Explain the reasoning behind providing paralysis in electroconvulsive therapy.</p></list-item><list-item><p>Identify the most common adverse advents associated with electroconvulsive therapy.</p></list-item><list-item><p>Summarize the induction, maintenance, and emergence of anesthesia for electroconvulsive therapy by interprofessional tea.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=132870&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=132870">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-132870.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Electroconvulsive therapy (ECT) is a treatment option for patients with pharmacotherapy-resistant depression, catatonia, bipolar disorder, and other psychiatric disorders, with depression&#x000a0;being the most common reason for receiving this treatment.<xref ref-type="bibr" rid="article-132870.r1">[1]</xref>&#x000a0;</p>
        <p>First introduced in the 1930s, this procedure involves a patient undergoing general anesthesia and&#x000a0;receiving an electrical stimulus to one or both brain hemispheres from an external device to induce a generalized seizure. Patients often see improvements in their mental health after these procedures.<xref ref-type="bibr" rid="article-132870.r2">[2]</xref>&#x000a0;The goal of anesthesia for ECTs is to provide hemodynamic stability, amnesia, and muscle relaxation to allow effective patient treatment.</p>
      </sec>
      <sec id="article-132870.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>During ECT, a seizure is induced by an external electrical device&#x000a0;while the patient is under general anesthesia. This results in a generalized tonic-clonic seizure with a duration that is variable. Seizures cause profound autonomic nervous system activity. First, the parasympathetic nervous system&#x000a0;is activated, resulting in possible bradycardia and even asystole. The bradycardia is typically short-lived and followed by a sympathetic surge that causes hypertension and tachycardia. This sympathetic stimulation can last for anywhere from 5 to 10 min after the seizure has been induced.</p>
        <p>The effect of a seizure causing a parasympathetic surge increases the risk of myocardial ischemia if the bradycardia is severe enough for too long. Glycopyrrolate, an anticholinergic medication, can be given to counteract the parasympathetic response such as increased salivation and bradycardia. Unfortunately, the administration of anticholinergic medications causes the opposite effect of producing tachycardia, which is exacerbated during the sympathetic response.</p>
        <p>During the sympathetic discharge, prolonged tachycardia and hypertension increase the risk of cardiovascular events due to increased myocardial demand and oxygen consumption. Sympathetic stimulation and the seizure itself cause an increase in cerebral blood flow and an increase in cerebral metabolic rate of oxygen, resulting in increased intracranial pressure. Increases in intraocular and intragastric pressure occur as well. Esmolol can be used to blunt the sympathetic response.<xref ref-type="bibr" rid="article-132870.r3">[3]</xref>&#x000a0;Patients can also have postictal states&#x000a0;with stroke-like symptoms or cognitive agitation, which can confuse the clinical picture as they are also recovering from general anesthesia at the same time.<xref ref-type="bibr" rid="article-132870.r4">[4]</xref></p>
      </sec>
      <sec id="article-132870.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Providing general anesthesia for ECT is&#x000a0;essential in every case and is only done without anesthesia in developing countries where proper equipment and personnel are not available. ECT is a first-line treatment for several disorders. When psychotic features and suicide risk are high, ECT is a useful initial treatment.&#x000a0; If a patient's depression has caused catatonia or psychomotor retardation involving the inability to eat or drink, then ECT is a viable treatment. It can provide fast relief if it is effective. One report indicates that for severe psychomotor depression, ECT provides up to 90% relief within two weeks.<xref ref-type="bibr" rid="article-132870.r5">[5]</xref>&#x000a0;Neuroleptic malignant syndrome is also an indication for ECT. Severe depression and psychotic features in pregnancy are conditions where ECT is used preferentially when medications can be harmful to the patient or the developing fetus.<xref ref-type="bibr" rid="article-132870.r6">[6]</xref>&#x000a0;</p>
        <p>ECT as a second-line treatment is mainly used when pharmacotherapy is ineffective or the patient's symptoms worsen.<xref ref-type="bibr" rid="article-132870.r7">[7]</xref>&#x000a0;In certain conditions, ECT is considered an experimental treatment with promising benefits such as treatment-resistant epilepsy, Parkinson disease, depression and tremors, and Tourette syndrome.<xref ref-type="bibr" rid="article-132870.r8">[8]</xref><xref ref-type="bibr" rid="article-132870.r9">[9]</xref><xref ref-type="bibr" rid="article-132870.r10">[10]</xref></p>
      </sec>
      <sec id="article-132870.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There are several contraindications to ECT. Most contraindications are relative and need special consideration. The anesthesia provider&#x000a0;must take into account each patient's comorbidities and address how a generalized seizure will affect them.&#x000a0; In most cases, pheochromocytoma and elevated intracranial pressure with mass effect at baseline are absolute contraindications.<xref ref-type="bibr" rid="article-132870.r11">[11]</xref> &#x000a0;</p>
        <p>An increase in intracranial or intraocular pressure is not tolerated very well for a patient with intracranial mass, retinal detachment, or intracerebral aneurysms. Patients with myocardial disease, cardiac arrhythmias, bleeding disorders, and pheochromocytoma&#x000a0;may not tolerate the&#x000a0;hemodynamic instability&#x000a0;from extreme parasympathetic and sympathetic stimulation during the procedure.<xref ref-type="bibr" rid="article-132870.r12">[12]</xref><xref ref-type="bibr" rid="article-132870.r13">[13]</xref></p>
      </sec>
      <sec id="article-132870.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>There are several items needed before performing ECT. The American Society of Standard of care for monitoring a patient under general anesthesia includes monitoring heart rhythm with an electrocardiogram and monitoring heart rate, oxygenation, ventilation, and blood pressure. A tourniquet should be&#x000a0;used&#x000a0;on one of the patient's extremities to prevent the muscle relaxant from affecting that extremity, which&#x000a0;allows monitoring of the effectiveness of the motor portion of the seizure.&#x000a0; Electroencephalogram (EEG) monitors, or processed EEG, monitor the status of the brain during the seizure. Emergency airway equipment should be readily available. A soft bite block is provided in the oropharynx to prevent tongue and tooth injury, as a generalized epileptic seizure has been shown to cause such trauma even in the setting of muscle relaxation.<xref ref-type="bibr" rid="article-132870.r14">[14]</xref>&#x000a0;A bag-valve mask and a simple oxygen face mask should be available to administer oxygen. A suctioning device is a necessity to help clear secretions.</p>
      </sec>
      <sec id="article-132870.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>The personnel required for ECT are a psychiatrist, a nurse, and a trained anesthetic provider who can perform general anesthesia for the patient. These requirements vary by state and governing body.</p>
      </sec>
      <sec id="article-132870.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>An intravenous catheter (IV)&#x000a0; is placed before the induction of anesthesia. Typically, a patient breathes 100% oxygen before induction of anesthesia. The patient's&#x000a0;vital signs are monitored throughout the procedure. The intravenous anesthetic of choice is administered, followed by hyperventilation with a bag mask to induce hypocapnia&#x000a0;which lowers cerebral blood flow and reduces the seizure threshold. After general anesthesia is successfully induced, a muscle relaxant is given to prevent myalgias and musculoskeletal injuries during the seizure. A tourniquet is commonly placed on one of the lower extremities to block muscle relaxants from reaching the area. This helps monitor the motor portion of the seizure by allowing personnel to observe the tonic and clonic activity of the lower extremity. A soft bite block is then placed to prevent the patient from developing an oral injury during the seizure.&#x000a0; The electrical stimulus is then administered to induce the seizure and is monitored by a processed EEG.</p>
        <p>The goal is for the seizure to last around 25 to 75 seconds but no shorter than 15 seconds.<xref ref-type="bibr" rid="article-132870.r15">[15]</xref><xref ref-type="bibr" rid="article-132870.r16">[16]</xref>&#x000a0;More prolonged seizures can be desirable if the patient has had ECTs that were less than 15 seconds in the past. The patient is then recovered in a post-anesthesia unit having their neurological status and hemodynamics monitored until it is appropriate for them to return home or to their assigned hospital room.</p>
        <p>There are a variety of anesthetic agents and muscle relaxants that are used to induce anesthesia for ECT. Most dosing regimens for medications administered should be used in the lowest effective dose.</p>
        <p>Methohexital is considered the gold standard for induction of anesthesia for ECT. It is a barbiturate that stimulates Gamma-aminobutyric acid (GABA) receptors which are the main inhibitory receptors in the brain. Methohexital produces anesthesia for approximately 4 to 7 minutes, which is ideal for ECT. It does not affect seizure threshold and, compared to propofol, does not shorten seizure length.<xref ref-type="bibr" rid="article-132870.r17">[17]</xref> Methohexital causes moderate cardiac depression, which helps counteract the sympathetic discharge produced by a seizure. The initial dose is usually 1 to 1.5 mg/kg.<xref ref-type="bibr" rid="article-132870.r18">[18]</xref>&#x000a0;</p>
        <p>Etomidate is a unique drug that also works by activating GABA receptors in the brain. Studies have shown that it tends to produce a longer seizure compared to propofol.<xref ref-type="bibr" rid="article-132870.r19">[19]</xref>&#x000a0; Etomidate does not cause cardiac depression, so the sympathetic discharge tends to be elevated when used as the sole anesthetic for ECT. Supplementing with an intravenous opioid such as remifentanil or a beta-blocker like esmolol to inhibit sympathetic discharge is common. Etomidate is known to cause adrenal suppression and should be avoided in patients with known adrenal insufficiency or critical illness. A dose of 0.3 mg/kg of etomidate is given to induce general anesthesia, lasting around 5 to 10 minutes.<xref ref-type="bibr" rid="article-132870.r20">[20]</xref><xref ref-type="bibr" rid="article-132870.r21">[21]</xref>&#x000a0;</p>
        <p>Propofol also acts as a GABA agonist. However, it tends to shorten seizure duration as it increases the seizure threshold. It is used in ECT as an anesthetic agent when previous seizures induced by ECTs have been prolonged and when a rapid onset is needed. Propofol is dosed at 1.5 to 2 mg/kg.<xref ref-type="bibr" rid="article-132870.r22">[22]</xref>&#x000a0;</p>
        <p>Ketamine is N-methyl-D-aspartate (NMDA) antagonist, and it causes dissociative anesthesia as well as analgesia. It is not often used in ECT as it tends to increase seizure length and causes indirect myocardial stimulation. Ketamine also has antidepressant properties, and studies are ongoing determining its effectiveness as an adjunct for the treatment of depression. Doses of 1 to 2 mg/kg are typically used to induce adequate anesthesia.<xref ref-type="bibr" rid="article-132870.r23">[23]</xref>&#x000a0;Ketamine has the potential side effect of causing psychomimetic delirium during recovery, vivid dreams, and hallucinations. This is often pretreated with a benzodiazepine.<xref ref-type="bibr" rid="article-132870.r24">[24]</xref><xref ref-type="bibr" rid="article-132870.r25">[25]</xref>&#x000a0;Recovery from ketamine is the slowest, followed by etomidate, methohexital, propofol when given for a short period.</p>
        <p>Sevoflurane is an option for induction of anesthesia in ECT. It has a slow onset compared to intravenous anesthetics. It can be helpful to initiate anesthesia to obtain IV access on a patient who is uncooperative awake. When used for a short period, sevoflurane has a quick recovery. In a systematic review, sevoflurane reduces seizure length more prominently than propofol, barbiturates, and ketamine.<xref ref-type="bibr" rid="article-132870.r26">[26]</xref>&#x000a0;Sevoflurane does not attenuate the sympathetic stimulation to the extent as other induction agents, so opioids or beta-blockers are often used to maintain hemodynamic stability.<xref ref-type="bibr" rid="article-132870.r27">[27]</xref>&#x000a0;Sevoflurane enhances muscular blockade compared to intravenous anesthetics.&#x000a0;</p>
        <p>Succinylcholine is the preferred muscle relaxant for ECT. It is a depolarizing neuromuscular blocker and is given in doses of 1 mg/kg to produce adequate muscle relaxation for intubating conditions within 30 seconds of administration. It typically lasts 5&#x000a0;to 8 minutes.<xref ref-type="bibr" rid="article-132870.r28">[28]</xref> Succinylcholine raises the serum potassium by 0.5 meq/L after IV administration. In the setting of elevated plasma potassium and conditions that can cause an exaggerated increase in serum potassium when succinylcholine is given, lethal arrhythmias occur, and succinylcholine should be avoided.<xref ref-type="bibr" rid="article-132870.r29">[29]</xref>&#x000a0;There is no reversal agent for succinylcholine, but typically that is not needed since its duration of action is short. Succinylcholine and sevoflurane should be avoided if the patient has a history of malignant hyperthermia, as these are triggering agents for malignant hyperthermia.</p>
        <p>Nondepolarizing neuromuscular blocking agents are good alternatives to succinylcholine, with the most common being rocuronium.&#x000a0;Rocuronium is given at doses of 0.6 mg/kg to produce intubating conditions. Its effects last around 35 minutes. If the patient is on an antiepileptic medication or mood stabilizer such as lithium, the anesthetic provider must be aware. Lithium can delay the onset and prolong the actions of succinylcholine and nondepolarizing neuromuscular blocking agents.<xref ref-type="bibr" rid="article-132870.r30">[30]</xref>&#x000a0;Antiepileptic medications acutely can prolong the effects of nondepolarizing neuromuscular blocking agents, but when chronically taken, resistance to these muscle relaxants occurs, requiring larger doses.<xref ref-type="bibr" rid="article-132870.r31">[31]</xref></p>
      </sec>
      <sec id="article-132870.s9" sec-type="Complications">
        <title>Complications</title>
        <p>Complications in ECT, although rare, do occur. The anesthetic provider should be monitoring the patient at all times. The most common side effects of ECTs are headaches and cognitive impairment.<xref ref-type="bibr" rid="article-132870.r1">[1]</xref>&#x000a0;These tend to be temporary. The cognitive impairment is compounded by the administration of general anesthesia, the underlying psychiatric disorder, and the induced seizure.&#x000a0;A seizure that lasts too long can result in status epilepticus. This condition requires prompt treatment in the form of administering benzodiazepine or propofol until termination of seizure. Status epilepticus is more common when pretreatment with theophylline is used to prolong the seizure.<xref ref-type="bibr" rid="article-132870.r32">[32]</xref>&#x000a0;</p>
        <p>Upon induction of general anesthesia and muscle relaxation, it may be difficult to mask ventilate the patient. Depending on which medications were used, letting the patient wake up and return to spontaneous ventilation may be the best option. Endotracheal intubation may be required to prevent severe hypoxia.</p>
        <p>During recovery in the post-anesthesia care unit, myocardial infarction, ischemic or hemorrhagic stroke are possible. Evaluation by cardiology or neurology should be implemented if these conditions are noticed. Patients emerging from anesthesia may also become agitated and experience pain. Postictal side effects such as paralysis or mania are also possible.</p>
        <p>Patients with deep brain stimulators or cardiac devices require special considerations. Deep brain stimulators can cause electrical interference when inducing a generalized seizure and should thus be turned off. A physician specialized in deep brain stimulation should be consulted.<xref ref-type="bibr" rid="article-132870.r33">[33]</xref> Patients with pacemakers and other cardiac devices are primarily considered safe to undergo ECT with only ECG monitoring. There is a very low likelihood that the electrical impulse interferes with the cardiac device.<xref ref-type="bibr" rid="article-132870.r34">[34]</xref>&#x000a0;A magnet should be readily available in case of an emergency. The anesthetic provider should communicate with the patient's cardiologist to determine the severity of illness and risk of undergoing general anesthesia.</p>
      </sec>
      <sec id="article-132870.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>ECT is an effective treatment for pharmacotherapy-resistant depression and other severe psychiatric disorders. Its effects are quickly seen, but some patients may require multiple sessions of this therapy. Providing general anesthesia for ECT is standard and has been the case since the 1950s. Anesthesia for ECT provides a safe environment for a generalized epileptic seizure to take place.&#x000a0; Treatment of hemodynamic instability and prevention of painful and detrimental side effects are possible through a carefully planned anesthetic.</p>
        <p>The ideal anesthetic agent provides amnesia with minimal effects on hemodynamic stability and seizure duration. An anesthetic agent that does affect seizure duration might be desirable if the patients' previous seizure during ECT was too long or short. Muscle relaxation protects the musculoskeletal system from the tonic and clonic actions of a generalized seizure. There are enough options and ways to provide anesthesia for ECT to suit most patients' needs. Alterations are made by the anesthesiologist, who recognizes reactions, patient discomfort, and side effects. Today, ECT is seldom performed without the use of general anesthesia except in developing countries. Musculoskeletal injury and post-traumatic stress disorder are not uncommon when enduring ECT without anesthesia.<xref ref-type="bibr" rid="article-132870.r35">[35]</xref><xref ref-type="bibr" rid="article-132870.r36">[36]</xref>&#x000a0;Anesthesia prevents harm and trauma to the patient while enabling them to undergo a procedure that significantly improves their psychiatric disorder.</p>
      </sec>
      <sec id="article-132870.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>ECT provides patients&#x000a0;with certain psychiatric disorders a treatment option for improvement in their mental state. Performing ECT requires an entire team composed of interprofessional colleagues, including anesthesiologists, psychiatrists, and nurses.<xref ref-type="bibr" rid="article-132870.r37">[37]</xref><xref ref-type="bibr" rid="article-132870.r16">[16]</xref>&#x000a0;[Level 5]</p>
        <p>Prior to undergoing ECT, a patient should be evaluated by an anesthetic provider to ensure the patient is safe to undergo general anesthesia and consent to the use of general anesthesia. Additionally, this allows the anesthetic provider to determine if the patient's comorbidities and current medication regimen require alterations to the anesthetic plan. The anesthesia team should also coordinate with the psychiatrist to determine the severity of the patient's psychiatric disorders and the length of seizure desired. A nurse is present before, during, and after the procedure to ensure the patient is ready for the procedure and monitored afterward. Nursing staff help to position the patient and to make sure all safety guidelines are followed. During recovery, nurses help recognize side effects and reactions to either the anesthesia or seizure.</p>
      </sec>
      <sec id="article-132870.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=132870&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=132870">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/132870/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=132870">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-132870.s13">
        <title>References</title>
        <ref id="article-132870.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moksnes</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Ilner</surname>
                <given-names>SO</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy--efficacy and side-effects.</article-title>
            <source>Tidsskr Nor Laegeforen</source>
            <year>2010</year>
            <month>Dec</month>
            <day>16</day>
            <volume>130</volume>
            <issue>24</issue>
            <fpage>2460</fpage>
            <page-range>2460-4</page-range>
            <pub-id pub-id-type="pmid">21164584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Payne</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Prudic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.</article-title>
            <source>J Psychiatr Pract</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>346</fpage>
            <page-range>346-68</page-range>
            <pub-id pub-id-type="pmid">19820553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kadiyala</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Kadiyala</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy.</article-title>
            <source>Indian J Anaesth</source>
            <year>2017</year>
            <month>May</month>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>373</fpage>
            <page-range>373-380</page-range>
            <pub-id pub-id-type="pmid">28584345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaines</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Rees</surname>
                <given-names>DI</given-names>
              </name>
            </person-group>
            <article-title>Anesthetic considerations for electroconvulsive therapy.</article-title>
            <source>South Med J</source>
            <year>1992</year>
            <month>May</month>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>469</fpage>
            <page-range>469-82</page-range>
            <pub-id pub-id-type="pmid">1585198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petrides</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Rush</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rummans</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Biggs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bailine</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.</article-title>
            <source>J ECT</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>244</fpage>
            <page-range>244-53</page-range>
            <pub-id pub-id-type="pmid">11731725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baghai</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>M&#x000f6;ller</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy and its different indications.</article-title>
            <source>Dialogues Clin Neurosci</source>
            <year>2008</year>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-17</page-range>
            <pub-id pub-id-type="pmid">18472488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warneke</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Managing resistant depression. When patients do not respond to therapy.</article-title>
            <source>Can Fam Physician</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>39</volume>
            <fpage>843</fpage>
            <page-range>843-50</page-range>
            <pub-id pub-id-type="pmid">8495142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strassnig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Riedel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy in a patient with Tourette's syndrome and co-morbid Obsessive Compulsive Disorder.</article-title>
            <source>World J Biol Psychiatry</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>164</fpage>
            <page-range>164-6</page-range>
            <pub-id pub-id-type="pmid">15346542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Regenold</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Taller</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy for epilepsy and major depression.</article-title>
            <source>Am J Geriatr Psychiatry</source>
            <year>1998</year>
            <season>Spring</season>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>180</fpage>
            <page-range>180-3</page-range>
            <pub-id pub-id-type="pmid">9581214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fregni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pascual-Leone</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>76</volume>
            <issue>12</issue>
            <fpage>1614</fpage>
            <page-range>1614-23</page-range>
            <pub-id pub-id-type="pmid">16291882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy: a review of history, patient selection, technique, and medication management.</article-title>
            <source>South Med J</source>
            <year>2007</year>
            <month>May</month>
            <volume>100</volume>
            <issue>5</issue>
            <fpage>494</fpage>
            <page-range>494-8</page-range>
            <pub-id pub-id-type="pmid">17534086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buday</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Albrecht</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mare&#x00161;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Podgorn&#x000e1;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hor&#x000e1;&#x0010d;kov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kali&#x00161;ov&#x000e1;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Raboch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Anders</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Brain Tumors and Electroconvulsive Therapy: A Literature Overview of the Last 80 Years.</article-title>
            <source>Front Neurol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>723</fpage>
            <pub-id pub-id-type="pmid">32849199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pozuelo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Malone</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy: what the internist needs to know.</article-title>
            <source>Cleve Clin J Med</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>74</volume>
            <issue>9</issue>
            <fpage>679</fpage>
            <page-range>679-85</page-range>
            <pub-id pub-id-type="pmid">17879522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chanpattana</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kojima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Intakorn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kitphati</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>ECT practice in Japan.</article-title>
            <source>J ECT</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>139</fpage>
            <page-range>139-44</page-range>
            <pub-id pub-id-type="pmid">16127301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jindal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sidhu</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Kumari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kamboj</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Etomidate versus Propofol for Motor Seizure Duration during Modified Electroconvulsive Therapy.</article-title>
            <source>Anesth Essays Res</source>
            <year>2020</year>
            <season>Jan-Mar</season>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-67</page-range>
            <pub-id pub-id-type="pmid">32843794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wojdacz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>&#x0015a;wi&#x00119;cicki</surname>
                <given-names>&#x00141;</given-names>
              </name>
              <name>
                <surname>Antosik-W&#x000f3;jci&#x00144;ska</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the effect of intravenous anesthetics used for anesthesia during electroconvulsive therapy on the hemodynamic safety and the course of ECT.</article-title>
            <source>Psychiatr Pol</source>
            <year>2017</year>
            <month>Dec</month>
            <day>30</day>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>1039</fpage>
            <page-range>1039-1058</page-range>
            <pub-id pub-id-type="pmid">29432502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Avramov</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy.</article-title>
            <source>Anesth Analg</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>81</volume>
            <issue>3</issue>
            <fpage>596</fpage>
            <page-range>596-602</page-range>
            <pub-id pub-id-type="pmid">7653829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martone</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Nagelhout</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Methohexital: a practical review for outpatient dental anesthesia.</article-title>
            <source>Anesth Prog</source>
            <year>1991</year>
            <season>Nov-Dec</season>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>195</fpage>
            <page-range>195-9</page-range>
            <pub-id pub-id-type="pmid">1842156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gazdag</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kocsis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tolna</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Iv&#x000e1;nyi</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia.</article-title>
            <source>J ECT</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>225</fpage>
            <page-range>225-9</page-range>
            <pub-id pub-id-type="pmid">15591855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Upchurch</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Grijalva</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Russ</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Semler</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ehrenfeld</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>High</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>McNaughton</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Self</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Etomidate and Ketamine for Induction During Rapid Sequence Intubation of&#x000a0;Adult Trauma Patients.</article-title>
            <source>Ann Emerg Med</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-33.e2</page-range>
            <pub-id pub-id-type="pmid">27993308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forman</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Clinical and molecular pharmacology of etomidate.</article-title>
            <source>Anesthesiology</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>114</volume>
            <issue>3</issue>
            <fpage>695</fpage>
            <page-range>695-707</page-range>
            <pub-id pub-id-type="pmid">21263301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Dubey</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Watti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lalwani</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: A comparative study.</article-title>
            <source>Indian J Anaesth</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>296</fpage>
            <page-range>296-301</page-range>
            <pub-id pub-id-type="pmid">20882170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hooten</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review.</article-title>
            <source>J ECT</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>208</fpage>
            <page-range>208-23</page-range>
            <pub-id pub-id-type="pmid">18628717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zanos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moaddel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Riggs</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Highland</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Georgiou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>EFR</given-names>
              </name>
              <name>
                <surname>Albuquerque</surname>
                <given-names>EX</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Zarate</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.</article-title>
            <source>Pharmacol Rev</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>621</fpage>
            <page-range>621-660</page-range>
            <pub-id pub-id-type="pmid">29945898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jankauskas</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Necyk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chue</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chue</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A review of ketamine's role in ECT and non-ECT settings.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2018</year>
            <volume>14</volume>
            <fpage>1437</fpage>
            <page-range>1437-1450</page-range>
            <pub-id pub-id-type="pmid">29922060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aoki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Suwa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawashima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tajika</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sunada</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Murai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takekita</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Sevoflurane in electroconvulsive therapy: A systematic review and meta-analysis of randomised trials.</article-title>
            <source>J Psychiatr Res</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>141</volume>
            <fpage>16</fpage>
            <page-range>16-25</page-range>
            <pub-id pub-id-type="pmid">34171759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pekel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Postaci</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Ayta&#x000e7;</surname>
                <given-names>&#x00130;</given-names>
              </name>
              <name>
                <surname>Karasu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kele&#x0015f;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>&#x0015e;en</surname>
                <given-names>&#x000d6;</given-names>
              </name>
              <name>
                <surname>Dikmen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>G&#x000f6;ka</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Sevoflurane versus propofol for electroconvulsive therapy: effects on seizure parameters, anesthesia recovery, and the bispectral index.</article-title>
            <source>Turk J Med Sci</source>
            <year>2016</year>
            <month>Apr</month>
            <day>19</day>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>756</fpage>
            <page-range>756-63</page-range>
            <pub-id pub-id-type="pmid">27513252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrade</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tharyan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Thirunavukarasu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kallivayalil</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Nagpal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bohra</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mohandas</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Position statement and guidelines on unmodified electroconvulsive therapy.</article-title>
            <source>Indian J Psychiatry</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-33</page-range>
            <pub-id pub-id-type="pmid">22988318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marsch</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bucher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pargger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schumann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aebi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hunziker</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Siegemund</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial.</article-title>
            <source>Crit Care</source>
            <year>2011</year>
            <month>Aug</month>
            <day>16</day>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>R199</fpage>
            <pub-id pub-id-type="pmid">21846380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hill</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Lithium carbonate and neuromuscular blocking agents.</article-title>
            <source>Anesthesiology</source>
            <year>1977</year>
            <month>Feb</month>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-6</page-range>
            <pub-id pub-id-type="pmid">835845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soriano</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Martyn</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance.</article-title>
            <source>Clin Pharmacokinet</source>
            <year>2004</year>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-81</page-range>
            <pub-id pub-id-type="pmid">14748617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devanand</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Decina</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sackeim</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Prudic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Status epilepticus following ECT in a patient receiving theophylline.</article-title>
            <source>J Clin Psychopharmacol</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <pub-id pub-id-type="pmid">3372714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeoh</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Manninen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kalia</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Venkatraghavan</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Anesthesia considerations for patients with an implanted deep brain stimulator undergoing surgery: a review and update.</article-title>
            <source>Can J Anaesth</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>308</fpage>
            <page-range>308-319</page-range>
            <pub-id pub-id-type="pmid">28028671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacPherson</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Loo</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy in patients with cardiac pacemakers.</article-title>
            <source>Anaesth Intensive Care</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>470</fpage>
            <page-range>470-4</page-range>
            <pub-id pub-id-type="pmid">16913344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Payne</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Prudic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy: Part II: a biopsychosocial perspective.</article-title>
            <source>J Psychiatr Pract</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>369</fpage>
            <page-range>369-90</page-range>
            <pub-id pub-id-type="pmid">19820554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ray</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>How bad was unmodified electroconvulsive therapy! A retrospective study.</article-title>
            <source>Indian J Psychiatry</source>
            <year>2016</year>
            <season>Apr-Jun</season>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>212</fpage>
            <page-range>212-5</page-range>
            <pub-id pub-id-type="pmid">27385857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132870.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shukla</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>Modified versus unmodified ect.</article-title>
            <source>Indian J Psychiatry</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>445</fpage>
            <page-range>445-6</page-range>
            <pub-id pub-id-type="pmid">21407989</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
